Prescriber Attitudes Toward NTI Drugs and Substitution: What Doctors Really Think
Prescribers have deep concerns about substituting generic versions of narrow therapeutic index (NTI) drugs due to small changes in blood levels that can cause serious harm. Despite FDA assurances, real-world data shows substitution risks, communication gaps, and persistent brand use among doctors.
Continue reading...